Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study

PURPOSE: Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been suggested as promising biomarkers and we here evaluated whether a miRNA profile could be identified, sub-grouping ER+ breast cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyng, Maria B., Lænkholm, Anne-Vibeke, Søkilde, Rolf, Gravgaard, Karina H., Litman, Thomas, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356496/
https://www.ncbi.nlm.nih.gov/pubmed/22623953
http://dx.doi.org/10.1371/journal.pone.0036170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356496/
https://www.ncbi.nlm.nih.gov/pubmed/22623953
http://dx.doi.org/10.1371/journal.pone.0036170

Ejemplares similares